Advancing industry standards
Anhydrous bases
and USP <795>
Under USP <795>, a non-sterile compounded preparation using a base with a water activity less than 0.60 (anhydrous) allows for default BUDs. If using an anhydrous base, USP <795> permits a default BUD assignment of 90 days for oral liquids and 180 days for other forms. Explore our comprehensive offering of anhydrous bases to support diverse healthcare niches and unique patient requirements.

Featured products

Scientifically formulated to contain several ingredients to promote drug delivery of lipophilic and hydrophilic APIs while providing a soft, moisturizing feel.
Our commitment to excellence in research and testing
Are your SOPs
up-to-date?
With the implementation of USP <795>, SOPs are now mandated with more stringent documentation requirements. These include the documentation of personnel training, equipment records, release testing, complaints, and adverse events. Explore our comprehensive list of over 150 sterile and non-sterile SOP templates to support your USP compliance.
Are you compounding
in a hood?
According to USP <795>, any component of a compounded preparation not prepared in a hood must be evaluated for its potential to generate airborne chemical particles to reduce the potential exposure to personnel or contamination of the facility.
Explore our comprehensive offering of powder containment hoods to support your USP <795> compliance.

LP3 Network
educational offerings
Our educational programs ensure pharmacists have the expertise and resources to comply with USP <795>, USP <800>, safety data sheets, certificates of analysis, and facility SOPs while mastering hand hygiene, garbing, mixing, and proper equipment use.
Hear from our partners
"Being a partner with Medisca has been such a fulfilling experience. Having quick access to their experienced team’s compounding knowledge has been invaluable for developing formulas, creating and updating SOPs, and inquiring about the newest technology and equipment."
Christian Stella
PharmD, ABAAHP, FAAMM Pharmacist and CEO